Delivery Order SPE2DB20D3103-SPE2DB25FN2R2

Award Date 4/2/25
Potential Completion Date 4/3/25
Potential Value $9.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,403.83, is for the delivery of 4,566,963 units of Januvia 100 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of January 17, 2025 and does not have a set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,134.52, is for the supply of JANUVIA 100 MG TABLET 1000S, a medication used to treat type 2 diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of November 4, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Januvia 100 mg tablets, a prescription medication used to treat type 2 diabetes. The contract is a firm fixed-price delivery order with a ceiling value of $4,549.83 and a completion date of September 14, 2023. This contract is not designated as a set-aside....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Januvia 100 mg tablets, a medication used to manage diabetes. The contract has a ceiling value of $3,274.38 and runs through March 27, 2025. It is a firm-fixed-price contract, without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JANUVIA 100 MG TABLET 90S, a medication used to treat type 2 diabetes. The contract has a ceiling value of $2,681.58 and a completion date of April 1, 2025. It is a Firm Fixed Price contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This is a $13,592.14 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JANUVIA 100 MG TABLET 1000S, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of March 8, 2024. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any subcontractors. This contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JANUVIA 100 MG TABLET 90S, a medication used to treat type 2 diabetes. The contract has a ceiling value of $26,545.90 and a period of performance ending on April 1, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award, valued at $1,091.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Januvia 100 mg tablets, a medication used to treat type 2 diabetes. The contract is a Firm Fixed Price Delivery Order with a completion date of March 28, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JANUVIA 100 MG TABLET 90S, a medication used in the treatment of diabetes, with a ceiling value of $5,472.00 and a period of performance through January 2, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract is for the supply of Januvia 50 mg tablets, a medication used to treat type 2 diabetes. The contract has a ceiling value of $2,329.20 and a period of performance ending on March 7, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FN2R2
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Januvia 100 mg tablets, a medication used to treat type 2 diabetes. The contract is a firm fixed-price delivery order with a ceiling value of $9,108.56 and a period of performance through April 3, 2025. AmerisourceBergen Drug Corp is the prime contractor, and the contract does not have a set-aside designation, indicating open competition. This contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen Drug Corp and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/2/25, 10:51 PM